Zentiva Champions Health Reforms for a Sustainable Future
Health is a fundamental right, and Zentiva firmly believes in ensuring that every individual in Europe has access to the essential medicines they need. The company supports the European Union’s commitment to the principle of leaving no one behind, aligning with global initiatives like the UN Sustainable Development Goal (SDG) 3, which emphasizes health and well-being for all. As the conversation surrounding pharmaceutical legislation reform evolves, Zentiva proudly joins the clarion call from Europe’s off-patent medicine sector, advocating for a healthcare system that prioritizes the needs of patients.
Ensuring Access to Medicines
The ongoing reform discussions are significantly vital for securing health for all citizens in Europe. It goes beyond mere policy; it is about guaranteeing that every person has unfettered access to the medications vital for their well-being. By avoiding shortages and fostering local production, this reform aims to create resilient health systems that are both accessible and equitable. Furthermore, the focus on robust industry practices is crucial for promoting sustainability, including minimizing carbon emissions and transitioning to renewable energy sources in manufacturing processes.
Dialogue and Action Among Decision-Makers
Zentiva is encouraged by recent dialogues with key figures in the European health landscape, including discussions held with European Health Commissioner Olivér Várhelyi. Such interactions are critical for transforming conversations into actionable outcomes that enhance the accessibility and affordability of essential medicines. It is imperative for Europe to accept its responsibility in finalizing these important pharmaceutical reforms to protect and support patients.
Leadership Commitment to Sustainable Solutions
CEO Steffen Saltofte emphasizes the necessity for meaningful legislation that is fair and effective. He highlights, "The current engagement with the European Commission is a step in the right direction. The off-patent medicine sector is committed to investing in Europe and prioritizing patients. However, for true progress, the EU needs to provide clear incentives, support local manufacturing, and eliminate barriers that hinder patient access to medicines. Together, we can create a sustainable future for Europe’s healthcare system. The implications of isolated actions must be understood to prevent undermining essential medicines availability and accessibility."
Your Role in the Future of Healthcare
Zentiva calls upon decision-makers to establish a unified market with harmonized principles that promote swift access to medicines, prevent duplication in regulatory processes, and ensure equal treatment for all patients across Europe. Enhancing competition immediately following the expiration of patents is essential for making treatments more affordable. Furthermore, coordination across the EU to mitigate medicine shortages through advanced digital tools is necessary for effective healthcare delivery.
Commitment to Innovation and Environmental Responsibility
Encouraging innovation in off-patent medicines, which address pressing health and environmental challenges, will help to sustain health outcomes for the population. Moreover, the principles laid out in the Critical Medicines Act should be expanded to encompass the entire sector. It is vital for everyone to have access to a diverse range of medicines to maintain their health.
Empowering Action on Environmental Legislation
Additionally, the existing Environmental legislation related to the Urban Wastewater Treatment Directive (UWWTD) needs thorough examination and adjustment to align with the necessities of healthcare provision.
About Zentiva
Zentiva prides itself on fostering health and wellness for all generations. Operating as a leading European firm, we are dedicated to developing, manufacturing, and supplying high-quality, affordable medicines to over 100 million individuals across 30 countries. Our facilities and a diverse network of manufacturing partners ensure the security of supply for those who rely on our products.
We are a vibrant team of over 5,000 individuals united by our mission to deliver high-quality, budget-friendly medicines for community needs. At Zentiva, we foster an inclusive workplace where all team members feel valued and empowered to contribute fully to our objectives.
With roots tracing back over five centuries to a small pharmacy in Prague, we are focused on sustainability today to ensure that Zentiva can serve future generations for many years to come.
Frequently Asked Questions
What is Zentiva's stance on healthcare access?
Zentiva advocates strongly for equitable access to affordable healthcare and essential medicines for all individuals in Europe.
How is Zentiva involved in pharmaceutical reforms?
Zentiva actively participates in discussions about pharmaceutical legislation, emphasizing the need for policies that prioritize patient needs and accessibility.
What does the company believe about sustainability in healthcare?
Zentiva is committed to promoting sustainable practices in its operations and supports initiatives aimed at reducing carbon emissions and enhancing manufacturing resilience.
How does Zentiva interact with European health leaders?
Zentiva engages directly with European health officials to advocate for regulatory changes that improve medicine accessibility and affordability.
What is Zentiva's vision for the future?
The company aims to continue providing high-quality and affordable medicines while fostering a sustainable healthcare environment for future generations.
